Category: CBSA News

Colorado BioScience Association Announces Finalists to be Honored 21st Annual Awards Celebration, Presented by AGC Biologics

By: Colorado BioScience Association   Date: 10/15/2024

NEWS RELEASE For Immediate Release: October 16, 2024 Colorado BioScience Association Announces Finalists to be Honored 21st Annual Awards Celebration, Presented by AGC Biologics Edgewise Therapeutics...

Learn More

Weekly Policy Blog: Updates on IP Protections 

By: Colorado BioScience Association   Date: 10/01/2024

CBSA advocates for policies that sustain innovation and create high-wage, high value jobs in life sciences, including strong intellectual property (IP) protections, which are the foundation of technol...

Learn More

Strategic Life Sciences Partnerships Find a New Altitude

By: Colorado BioScience Association   Date: 09/30/2024

The mountains are calling at the 2024 Colorado BioScience Association Rocky Mountain Life Sciences Investor & Partnering Conference. By: Fitzsimons Innovation Community For the past 15 years, Elys...

Learn More

Weekly Policy Blog: Watching Congress: PPRV Program Reauthorization and the “Breakthrough Act” 

By: Colorado BioScience Association   Date: 09/23/2024

Congress is grappling with a busy and complex agenda before adjourning on September 27 through the election. Congress is on track to meet its deadline of October 1 to pass a government funding measure...

Learn More

Weekly Policy Blog: Industry Lawsuits Challenge the IRA’s Medicare Drug Price Negotiation Program 

By: Colorado BioScience Association   Date: 09/09/2024

The newly-announced “negotiated” prices for the first ten drugs subject to price controls under the Inflation Reduction Act (IRA) are set to go into effect for people with Medicare Part D prescription...

Learn More

Weekly Policy Blog: CMS Announces MFPs for First Set of Drugs Subject to Price Controls Under the IRA 

By: Colorado BioScience Association   Date: 09/03/2024

On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the new “negotiated” prices for the first ten Medicare Part D drugs subject to price controls under the Inflation R...

Learn More

Fitzsimons Innovation Community and the CU Innovations Program

By: Colorado BioScience Association   Date: 08/29/2024

A partnership building bright futures. By: Fitzsimons Innovation Community In almost every sentence where Fitzsimons Innovation Community is mentioned, so too is our proximity to and partnership with...

Learn More

Weekly Policy Blog: Transitional Coverage for Emerging Technologies (TCET) Final Notice and the “Breakthrough Act”

By: Colorado BioScience Association   Date: 08/26/2024

CBSA advocates for policies that improve patient access to life-saving, novel technologies. This August, the Centers for Medicare & Medicaid Services (CMS) released the long-awaited Transitional C...

Learn More

Colorado BioScience Association Highlights Investment Opportunities at the 2024 Rocky Mountain Life Sciences Investor & Partnering Conference

By: Colorado BioScience Association   Date: 07/30/2024

Presenting Companies Represent Transformative Technologies from the Rocky Mountain West DENVER, July 31, 2024 – Colorado BioScience Association (CBSA) highlights the momentum and opportunities in Colo...

Learn More

Adams County Economic Development: On the Frontlines of Growth in Colorado

By: Colorado BioScience Association   Date: 07/30/2024

Fitzsimons Innovation Community and so many more call this thriving community home. By: Fitzsimons Innovation Community If you ask the Economic Development team for Adams County Government what drives...

Learn More